Physician profile
Robert J Lamberts
NPI 1376543082
$3,331.17
in general payments reported to CMS, 2019-2025
15 companies · $194 in 2025
The $194 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.62 · 2020: $279 · 2021: $244 · 2022: $134 · 2023: $2,358 · 2024: $55.91 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,205 · Food and Beverage: $403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,205.00 |
| Food and Beverage | $403.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $2,341.75 | 2023-2025 | Quviviq, Quviviq |
| Lilly USA, LLC | $233.93 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $225.17 | 2019-2024 | Farxiga |
| Novo Nordisk INC | $212.01 | 2019-2025 | Ozempic, Rybelsus |
| Adlon Therapeutics L.P. | $47.48 | 2020-2021 | |
| Neos Therapeutics, LP | $41.80 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $39.76 | 2020-2021 | |
| Jazz Pharmaceuticals INC. | $36.20 | 2020 | |
| Halozyme INC | $36.10 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.78 | 2020 | |
| Novartis Pharmaceuticals Corporation | $20.40 | 2023 | |
| Azurity Pharmaceuticals, INC. | $18.13 | 2023 | Adthyza |
| Amgen INC. | $16.33 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.28 | 2022 | |
| Exact Sciences Corporation | $15.05 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Lamberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.